OCC — Orthocell Cashflow Statement
0.000.00%
- AU$272.55m
- AU$244.50m
- AU$9.23m
- 28
- 16
- 64
- 27
Annual cashflow statement for Orthocell, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 2.95 | 2.23 | 25.2 | 3.87 | 4.69 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.52 | -6.26 | 14.6 | -6.51 | -8.68 |
Capital Expenditures | -0.189 | -0.535 | -0.632 | -0.942 | -0.359 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -0.189 | -0.535 | -0.632 | -0.942 | -0.359 |
Financing Cash Flow Items | — | — | — | -0.123 | -0.882 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.594 | 1.49 | -0.165 | 3.24 | 17 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.11 | -5.31 | 13.8 | -4.2 | 8.01 |